[{"id":"fab7c1a5-865b-44d1-9464-2b668a7a8d95","acronym":"","url":"https://clinicaltrials.gov/study/NCT06626633","created_at":"2025-02-26T15:02:37.996Z","updated_at":"2025-02-26T15:02:37.996Z","phase":"Phase 1","brief_title":"2321GCCC: CRD3874-SI in Patients with Relapsed/refractory AML","source_id_and_acronym":"NCT06626633","lead_sponsor":"University of Maryland, Baltimore","biomarkers":" IFNG • TNFA • IL10 • STAT6 • IFI27 • IFNA1 • IL1B • NFKB2 • IRF7 • JUNB","pipe":"","alterations":" ","tags":["IFNG • TNFA • IL10 • STAT6 • IFI27 • IFNA1 • IL1B • NFKB2 • IRF7 • JUNB"],"overall_status":"Recruiting","enrollment":" Enrollment 36","initiation":"Initiation: 08/26/2024","start_date":" 08/26/2024","primary_txt":" Primary completion: 01/31/2026","primary_completion_date":" 01/31/2026","study_txt":" Completion: 01/31/2028","study_completion_date":" 01/31/2028","last_update_posted":"2024-10-04"}]